Catalyst Wire Dossier Catalyst Wire Dossier

ABC/3TC based regimens

abacavir/lamivudine-based regimens
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABC/3TC based regimens, covering 2019-04-23 to 2019-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL) [Phase 3]

See pricing